BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29359803)

  • 1. Disruption of mammalian SWI/SNF and polycomb complexes in human sarcomas: mechanisms and therapeutic opportunities.
    McBride MJ; Kadoch C
    J Pathol; 2018 Apr; 244(5):638-649. PubMed ID: 29359803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters.
    Nakayama RT; Pulice JL; Valencia AM; McBride MJ; McKenzie ZM; Gillespie MA; Ku WL; Teng M; Cui K; Williams RT; Cassel SH; Qing H; Widmer CJ; Demetri GD; Irizarry RA; Zhao K; Ranish JA; Kadoch C
    Nat Genet; 2017 Nov; 49(11):1613-1623. PubMed ID: 28945250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dangerous liaisons: interplay between SWI/SNF, NuRD, and Polycomb in chromatin regulation and cancer.
    Bracken AP; Brien GL; Verrijzer CP
    Genes Dev; 2019 Aug; 33(15-16):936-959. PubMed ID: 31123059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased ACTL6A occupancy within mSWI/SNF chromatin remodelers drives human squamous cell carcinoma.
    Chang CY; Shipony Z; Lin SG; Kuo A; Xiong X; Loh KM; Greenleaf WJ; Crabtree GR
    Mol Cell; 2021 Dec; 81(24):4964-4978.e8. PubMed ID: 34687603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SWI/SNF complex in cancer.
    Lu C; Allis CD
    Nat Genet; 2017 Jan; 49(2):178-179. PubMed ID: 28138149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex.
    Lindén M; Thomsen C; Grundevik P; Jonasson E; Andersson D; Runnberg R; Dolatabadi S; Vannas C; Luna Santamarίa M; Fagman H; Ståhlberg A; Åman P
    EMBO Rep; 2019 May; 20(5):. PubMed ID: 30962207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SWI/SNF complex-deficient soft tissue neoplasms: An update.
    Schaefer IM; Hornick JL
    Semin Diagn Pathol; 2021 May; 38(3):222-231. PubMed ID: 32646614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting epigenetic vulnerabilities in solid tumors: Novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers.
    Chabanon RM; Morel D; Postel-Vinay S
    Semin Cancer Biol; 2020 Apr; 61():180-198. PubMed ID: 31568814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies.
    Centore RC; Sandoval GJ; Soares LMM; Kadoch C; Chan HM
    Trends Genet; 2020 Dec; 36(12):936-950. PubMed ID: 32873422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAFfling pathologies: Alterations of BAF complexes in cancer.
    Arnaud O; Le Loarer F; Tirode F
    Cancer Lett; 2018 Apr; 419():266-279. PubMed ID: 29374542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SWI/SNF chromatin remodeling and human malignancies.
    Masliah-Planchon J; Bièche I; Guinebretière JM; Bourdeaut F; Delattre O
    Annu Rev Pathol; 2015; 10():145-71. PubMed ID: 25387058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling Complexes.
    Mashtalir N; D'Avino AR; Michel BC; Luo J; Pan J; Otto JE; Zullow HJ; McKenzie ZM; Kubiak RL; St Pierre R; Valencia AM; Poynter SJ; Cassel SH; Ranish JA; Kadoch C
    Cell; 2018 Nov; 175(5):1272-1288.e20. PubMed ID: 30343899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation by BAF (mSWI/SNF) chromatin remodeling complexes is indispensable for embryonic development.
    Nguyen H; Sokpor G; Pham L; Rosenbusch J; Stoykova A; Staiger JF; Tuoc T
    Cell Cycle; 2016 May; 15(10):1317-24. PubMed ID: 26986003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Alterations in Bone and Soft Tissue Tumors.
    Wojcik J; Cooper K
    Adv Anat Pathol; 2017 Nov; 24(6):362-371. PubMed ID: 28885261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian SWI/SNF complexes in cancer: emerging therapeutic opportunities.
    St Pierre R; Kadoch C
    Curr Opin Genet Dev; 2017 Feb; 42():56-67. PubMed ID: 28391084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma.
    Papp G; Changchien YC; Péterfia B; Pecsenka L; Krausz T; Stricker TP; Khoor A; Donner L; Sápi Z
    Mod Pathol; 2013 Mar; 26(3):393-403. PubMed ID: 23174932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COMPASS and SWI/SNF complexes in development and disease.
    Cenik BK; Shilatifard A
    Nat Rev Genet; 2021 Jan; 22(1):38-58. PubMed ID: 32958894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FET fusion oncoproteins interact with BRD4 and SWI/SNF chromatin remodelling complex subtypes in sarcoma.
    Lindén M; Vannas C; Österlund T; Andersson L; Osman A; Escobar M; Fagman H; Ståhlberg A; Åman P
    Mol Oncol; 2022 Jul; 16(13):2470-2495. PubMed ID: 35182012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma.
    Tsuda M; Fukuda A; Kawai M; Araki O; Seno H
    Cancer Sci; 2021 Feb; 112(2):490-497. PubMed ID: 33301642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional properties of mSWI/SNF chromatin remodeling complexes revealed through single-cell perturbation screens.
    Otto JE; Ursu O; Wu AP; Winter EB; Cuoco MS; Ma S; Qian K; Michel BC; Buenrostro JD; Berger B; Regev A; Kadoch C
    Mol Cell; 2023 Apr; 83(8):1350-1367.e7. PubMed ID: 37028419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.